Infants exposed to maternal type 1 diabetes: intrauterine epigenetic modifications and neurological development

Nieves Luisa González-González1, Enrique González-Dávila2, José Ramón Castro-Conde1,3

  • 1Obstetrics and Gynecology Department, Facultad de Ciencias de la Salud, Sección de Medicina. University of La Laguna (ULL), San Cristóbal de La Laguna, Tenerife, Spain.

Frontiers in Endocrinology
|February 26, 2026
PubMed

Insights

Maternal Type-1 diabetes is linked to infant neurodevelopmental changes via fetal DNA methylation. This pilot study found specific gene methylation differences associated with lower cognitive, language, and motor scores in exposed infants.

Area of Science:

  • Epigenetics
  • Developmental Neuroscience
  • Maternal Health

Background:

  • The impact of maternal Type-1 diabetes on infant neurodevelopment and its connection to fetal DNA methylation remains unexplored.
  • Investigating intrauterine epigenetic modifications in infants exposed to maternal diabetes is crucial for understanding neurodevelopmental outcomes.

Purpose of the Study:

  • To determine if neurodevelopmental outcomes in offspring of mothers with Type-1 diabetes are associated with intrauterine epigenetic changes in fetal DNA.
  • To explore the relationship between maternal diabetes, fetal DNA methylation, and infant neurodevelopment.

Main Methods:

  • A prospective, pilot case-control study comparing infants exposed to maternal Type-1 diabetes with control infants.
  • Analysis of cord blood DNA methylation using the TruSeq-Methyl-Capture-EPIC-Kit, covering over 3.3 million CpGs.
  • Assessment of infant neurodevelopment using the Bayley-III Scales and correlation with DNA methylation data.

Main Results:

  • Identified 108 differentially methylated genes in infants exposed to maternal diabetes, enriched in neurodevelopmental pathways like learning, synapse organization, and neurogenesis.
  • Significant methylation differences observed in key neurological genes including MYT1L, NRXN1, SHANK3, and KIRREL3.
  • Infants exposed to maternal diabetes showed lower Bayley-III scores in cognitive, language, and motor domains; specific gene methylation correlated with these scores.

Conclusions:

  • This study provides initial evidence supporting the hypothesis that neurodevelopmental alterations in offspring of mothers with Type-1 diabetes are linked to intrauterine DNA methylation changes.
  • These epigenetic changes, identifiable at birth, may contribute to observed neurodevelopmental differences.
  • Further research is needed to confirm these findings and elucidate the mechanisms involved.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
37.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K